This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, W. Articles by Smith, J. R. Search for Related Content PubMed PubMed Citation Articles by Zheng, W. Articles by Smith, J. R.

Population-Based Case-Control Study of CYP11A Gene Polymorphism and Breast Cancer Risk

¹ Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; ² Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China; and ³ Medical Research Service, VA Tennessee Valley Healthcare System, Nashville, Tennessee

Requests for reprints: Wei Zheng, Center for Health Services Research, 1215 21st Avenue South, Medical Center East, Suite 6000, Vanderbilt University Medical Center, Nashville, TN 37232-8300. Phone: (615) 936-0682; Fax: (615) 936-1269. E-mail: wei.zheng{at}vanderbilt.edu

The CYP11A gene encodes the cholesterol side-chain cleavage enzyme (P450scc) that catalyzes the first and rate-limiting step for the biosynthesis of sex hormones. A pentanucleotide repeat [(TAAAA)n] polymorphism in the 5' of the CYP11A gene has been reported to be related to the risk of polycystic ovary syndrome, an inherited endocrine disorder characterized by hyperandrogenemia. We investigated the association of this polymorphism with breast cancer risk in a population-based case-control study conducted among Chinese women in Shanghai. Genotype assays were completed for 1015 incident breast cancer cases and 1082 community controls. Three common alleles with 4, 6, or 8 TAAAA repeats were identified in the study population. The frequency of the 8 repeat allele was more common in cases (12.6%) than controls (8.5%) (odds ratio = 1.6, 95% confidence interval = 1.3–1.9; P < 0.0001). Compared to subjects who did not carry this allele, adjusted odds ratios were 1.5 (95% confidence interval = 1.2–1.9) and 2.9 (1.3–6.7) (P for trend, <0.001), respectively, for those who carried one and two copies of this allele. This positive association was observed in both pre- and postmenopausal women and all strata defined by major breast cancer risk factors, including years of menstruation, body mass index, and waist-to-hip ratio. The results from this study indicate that the TAAAA repeat polymorphism near the promoter region of the CYP11A gene may be an important susceptibility factor for breast cancer risk.

Key Words: Breast cancer • CYP11A • epidemiology • estrogen • genetic factors • polymorphism

This article has been cited by other articles:

				L. C. Sakoda, C. Blackston, J. A. Doherty, R. M. Ray, M. G. Lin, H. Stalsberg, D. L. Gao, Z. Feng, D. B. Thomas, and C. Chen Polymorphisms in Steroid Hormone Biosynthesis Genes and Risk of Breast Cancer and Fibrocystic Breast Conditions in Chinese Women Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1066 - 1073. [Abstract] [Full Text] [PDF]

				S. L. Deming, Z. Ren, Q. Cai, X.-O. Shu, W. Wen, J.-R. Long, Y.-T. Gao, and W. Zheng IGF-I and IGF-II Genetic Variation and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 255 - 257. [Full Text] [PDF]

				B. L. Yaspan, J. P. Breyer, Q. Cai, Q. Dai, J. B. Elmore, I. Amundson, K. M. Bradley, X.-O. Shu, Y.-T. Gao, W. D. Dupont, et al. Haplotype Analysis of CYP11A1 Identifies Promoter Variants Associated with Breast Cancer Risk Cancer Res., June 15, 2007; 67(12): 5673 - 5682. [Abstract] [Full Text] [PDF]

				S. H. Olson, E. V. Bandera, and I. Orlow Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review Am. J. Epidemiol., February 1, 2007; 165(3): 235 - 245. [Abstract] [Full Text] [PDF]

				V. W. Setiawan, I. Cheng, D. O. Stram, E. Giorgi, M. C. Pike, D. Van Den Berg, L. Pooler, N. P. Burtt, L. Le Marchand, D. Altshuler, et al. A Systematic Assessment of Common Genetic Variation in CYP11A and Risk of Breast Cancer Cancer Res., December 15, 2006; 66(24): 12019 - 12025. [Abstract] [Full Text] [PDF]

				W. Zheng, W.-H. Chow, G. Yang, F. Jin, N. Rothman, A. Blair, H.-L. Li, W. Wen, B.-T. Ji, Q. Li, et al. The Shanghai Women's Health Study: Rationale, Study Design, and Baseline Characteristics Am. J. Epidemiol., December 1, 2005; 162(11): 1123 - 1131. [Abstract] [Full Text] [PDF]

				M. S. Cicek, X. Liu, G. Casey, and J. S. Witte Role of Androgen Metabolism Genes CYP1B1, PSA/KLK3, and CYP11{alpha} in Prostate Cancer Risk and Aggressiveness Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2173 - 2177. [Abstract] [Full Text] [PDF]